Reach your audience. Get results.
Rely on the experience, guidance, and superior media targeting of Business Wire for your global press release distribution.
Public RelationsMaximize the reach of your news with our press release distribution services and partnerships. Investor RelationsReach and engage investors, shareholders, analysts, and media with our complete suite of IR services and tools. Distribution & AnalyticsTarget your news, reach your audiences, and understand the impact of your press releases with our analytics reports. |
Latest News
Today is May 13, 2024.
All times in Eastern Daylight Time.
-
Riveron Deepens Business Advisory Presence in South FloridaMIAMI--(BUSINESS WIRE)--Riveron, a national business advisory firm focused on serving the office of the CFO, private equity, and other capital providers, announced a strategic investment and leader... more »
-
Ajax Therapeutics Announces FDA Clearance of IND Application for AJ1-11095, a First-in-Class Type II JAK2 inhibitor, for the Treatment of MyelofibrosisNEW YORK & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ajax Therapeutics, Inc., a biopharmaceutical company developing next generation JAK inhibitors for patients with myeloproliferative neoplasms (MPNs), t... more »
-
Resumen: GemaTEG™ presenta DaTEG 1.0: una revolucionaria solución de gestión térmica para servidores de IABELLEVUE, Washington--(BUSINESS WIRE)--GemaTEG™ presenta DaTEG 1.0, una solución de gestión térmica que reduce significativamente los costes de consumo energético e impulsa el rendimiento de los pr... more »
-
Harrow Names Greg DiPasquale as Senior Vice President, Head of CommercialNASHVILLE, Tenn.--(BUSINESS WIRE)--Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, is pleased to announce the appointment of Greg DiPasquale as Senior Vice President, Head of ... more »
-
Quince Therapeutics Provides Business Update and Reports First Quarter 2024 Financial ResultsSOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company developing an innovative drug delivery technology designed to leverage a p... more »
-
D-Wave Reports First Quarter 2024 ResultsPALO ALTO, Calif.--(BUSINESS WIRE)--D-Wave Quantum Inc., (NYSE: QBTS) (“D-Wave” or the “Company”) a leader in commercial quantum computing systems, software, and services, today announced financial... more »
-
Bowhead Specialty Announces Launch of Initial Public OfferingNEW YORK--(BUSINESS WIRE)--Bowhead Specialty Holdings Inc. (the “Company”, “Bowhead Specialty”, “we” or “our”) announced today the launch of its initial public offering of 6,666,667 shares of its c... more »
-
Montrose Environmental Group to Present With 3M at the Bank of America Securities 31st Annual Transportation, Airlines, and Industrials ConferenceLITTLE ROCK, Ark.--(BUSINESS WIRE)--Montrose Environmental Group, Inc. (the “Company,” “Montrose” or “MEG”) (NYSE: MEG) today announced that the Company will present at the Bank of America Securiti... more »
-
GRAIL to Host Capital Markets DayMENLO PARK, Calif.--(BUSINESS WIRE)--GRAIL, LLC announced today that it will host a virtual Capital Markets Day. more »
-
GemaTEG™ Introduces DaTEG 1.0: A Revolutionary Thermal Management Solution for AI ServersBELLEVUE, Wash.--(BUSINESS WIRE)--GemaTEG™ introduces DaTEG 1.0, a thermal management solution that significantly reduces energy costs and enhances chip performance in AI infrastructures. Why It Ma... more »
-
D-Wave and the University of Southern California Renew Multiyear Agreement to Advance Annealing Quantum Computing Research and AdoptionPALO ALTO, Calif. & LOS ANGELES--(BUSINESS WIRE)--D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave” or the “Company”), a leader in quantum computing systems, software, and services and the world’s first c... more »
-
Newron Reports Compelling Additional Data Documenting the Efficacy of Evenamide in Pivotal Study 008A in Poorly Responding Schizophrenia PatientsMILAN--(BUSINESS WIRE)--Newron reports new data from pivotal study 008A for chronic schizophrenia patients revealing clinically significant efficacy benefits over time. more »
-
Incyte Announces Intention to Buy Back up to $2.0 Billion of its Common StockWILMINGTON, Del.--(BUSINESS WIRE)--Incyte Announces Intention to Buy Back up to $2.0 Billion of its Common Stock more »
-
Leading Independent Proxy Advisory Firm ISS Recommends Xperi Stockholders Vote “FOR” All Company Nominees on the BLUE Proxy CardSAN JOSE, Calif.--(BUSINESS WIRE)--Xperi Inc. (NYSE: XPER) (the “Company” or “Xperi”) today announced that leading proxy advisory firm Institutional Shareholder Services (“ISS”) has recommended tha... more »
-
WisdomTree Sends Letter to Stockholders Outlining Board of Directors’ Essential Balance of Skillsets, Expertise and Institutional KnowledgeNEW YORK--(BUSINESS WIRE)--The Board of Directors of WisdomTree, Inc. (NYSE: WT), a global financial innovator, today issued a letter urging its stockholders to vote “FOR” all nine highly qualified... more »